OrbiMed Capital GP V LLC
SEC CIK 1615374 · EDGAR
BoughtSold
Most active insiders at PMVP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OrbiMed Capital GP V LLC | 10% | — | $1.52M |
| 2 | Mack David Henry | Pres, CEO, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-10-27 | 2025-10-23 | PMVP | PMV Pharmaceuticals, Inc. | OrbiMed Capital GP V LLC | 10% | S - Sale | $1.52 | -1.00M | 4.98M | -17% | -$1.52M |
| I | 2022-05-31 | 2022-05-26 | PMVP | PMV Pharmaceuticals, Inc. | OrbiMed Capital GP V LLC | 10% | S - Sale | $15.93 | -26.3K | 87.8K | -23% | -$418.2K |
| MI | 2022-05-10 | 2022-05-06+ | CMPX | Compass Therapeutics, Inc. | OrbiMed Capital GP V LLC | Dir, 10% | P - Purchase | $1.57 | +125.4K | 14.63M | +0.9% | +$197.3K |
| I | 2021-09-22 | 2021-09-20 | CRVS | Corvus Pharmaceuticals, Inc. | OrbiMed Capital GP V LLC | Dir, 10% | S - Sale | $6.09 | -1.11M | 6.94M | -14% | -$6.76M |
Purchase Sale Sale after option exercise All abbreviations